Shares

23 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q1 2024

May 01, 2024

SELL
$56.27 - $73.77 $163,858 - $214,818
-2,912 Reduced 17.29%
13,927 $961,000
Q4 2023

Jan 24, 2024

SELL
$59.06 - $75.72 $15,237 - $19,535
-258 Reduced 1.51%
16,839 $1.25 Million
Q3 2023

Oct 26, 2023

BUY
$65.94 - $99.04 $401,310 - $602,757
6,086 Added 55.27%
17,097 $1.17 Million
Q2 2023

Aug 10, 2023

SELL
$62.68 - $95.05 $110,066 - $166,907
-1,756 Reduced 13.75%
11,011 $1.03 Million
Q1 2023

May 04, 2023

SELL
$47.19 - $70.77 $1.77 Million - $2.66 Million
-37,519 Reduced 74.61%
12,767 $865,000
Q4 2022

Feb 09, 2023

SELL
$30.35 - $53.15 $361,589 - $633,229
-11,914 Reduced 19.15%
50,286 $2.49 Million
Q3 2022

Nov 10, 2022

SELL
$31.97 - $49.37 $1.2 Million - $1.85 Million
-37,456 Reduced 37.59%
62,200 $2.03 Million
Q2 2022

Jul 26, 2022

SELL
$35.61 - $76.23 $465,921 - $997,393
-13,084 Reduced 11.61%
99,656 $3.93 Million
Q1 2022

May 10, 2022

BUY
$57.56 - $82.54 $1.06 Million - $1.52 Million
18,357 Added 19.45%
112,740 $7.88 Million
Q4 2021

Feb 08, 2022

SELL
$72.5 - $100.68 $566,370 - $786,512
-7,812 Reduced 7.64%
94,383 $7.35 Million
Q3 2021

Nov 15, 2021

BUY
$90.24 - $124.05 $2.35 Million - $3.23 Million
26,000 Added 34.12%
102,195 $9.76 Million
Q2 2021

Aug 11, 2021

BUY
$93.66 - $139.27 $1.1 Million - $1.64 Million
11,766 Added 18.26%
76,195 $9.47 Million
Q1 2021

May 13, 2021

SELL
$116.57 - $155.01 $2.97 Million - $3.94 Million
-25,440 Reduced 28.31%
64,429 $8.49 Million
Q4 2020

Feb 10, 2021

BUY
$99.61 - $142.12 $4.16 Million - $5.93 Million
41,752 Added 86.77%
89,869 $11.9 Million
Q3 2020

Nov 12, 2020

BUY
$72.92 - $102.01 $743,711 - $1.04 Million
10,199 Added 26.9%
48,117 $4.91 Million
Q2 2020

Aug 11, 2020

BUY
$55.75 - $92.75 $139,319 - $231,782
2,499 Added 7.06%
37,918 $3.3 Million
Q1 2020

May 12, 2020

BUY
$37.9 - $104.44 $662,113 - $1.82 Million
17,470 Added 97.33%
35,419 $2.05 Million
Q4 2019

Feb 12, 2020

SELL
$77.66 - $99.74 $14 Million - $18 Million
-180,855 Reduced 90.97%
17,949 $1.66 Million
Q3 2019

Nov 12, 2019

BUY
$90.37 - $122.49 $964,067 - $1.31 Million
10,668 Added 5.67%
198,804 $18 Million
Q2 2019

Aug 13, 2019

BUY
$89.51 - $118.04 $14.8 Million - $19.5 Million
165,070 Added 715.64%
188,136 $22.2 Million
Q1 2019

May 13, 2019

BUY
$61.98 - $96.5 $161,024 - $250,707
2,598 Added 12.69%
23,066 $2 Million
Q3 2018

Nov 13, 2018

BUY
$48.29 - $80.6 $521,532 - $870,479
10,800 Added 111.71%
20,468 $1.62 Million
Q2 2018

Aug 14, 2018

BUY
$37.84 - $69.96 $365,837 - $676,373
9,668 New
9,668 $578,000

Others Institutions Holding EXAS

About EXACT SCIENCES CORP


  • Ticker EXAS
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Diagnostics & Research
  • Shares Outstandng 176,960,000
  • Market Cap $10.8B
  • Description
  • Exact Sciences Corporation provides cancer screening and diagnostic test products in the United States and internationally. The company offers Cologuard, a non-invasive stool-based DNA screening test to detect DNA and hemoglobin biomarkers associated with colorectal cancer and pre-cancer. It also provides Oncotype DX, a gene expression tests for...
More about EXAS
Track This Portfolio

Track Mirae Asset Global Investments Co., Ltd. Portfolio

Follow Mirae Asset Global Investments Co., Ltd. and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Mirae Asset Global Investments Co., Ltd., based on Form 13F filings with the SEC.

News

Stay updated on Mirae Asset Global Investments Co., Ltd. with notifications on news.